Previous studies also indicate that both the Ras-Raf-MEK-ERK and PI3K-AKT signaling pathways are constitutively activated through multiple mechanisms in cancers [14,82], suggesting that cross-talk and compensation exist between the two pathways. This evidence concerns the gene AKT1 and cancer.